Stephen O’Quinn

2.0k total citations
28 papers, 1.5k citations indexed

About

Stephen O’Quinn is a scholar working on Psychiatry and Mental health, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen O’Quinn has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 17 papers in Physiology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen O’Quinn's work include Migraine and Headache Studies (21 papers), Sympathectomy and Hyperhidrosis Treatments (15 papers) and Trigeminal Neuralgia and Treatments (14 papers). Stephen O’Quinn is often cited by papers focused on Migraine and Headache Studies (21 papers), Sympathectomy and Hyperhidrosis Treatments (15 papers) and Trigeminal Neuralgia and Treatments (14 papers). Stephen O’Quinn collaborates with scholars based in United States, United Kingdom and Australia. Stephen O’Quinn's co-authors include Richard B. Lipton, Roger Cady, Donna Gutterman, Walter F. Stewart, Charles B. Hall, Timothy A. Kuhn, Scott McNeal, Carolyn Watson, Fred D. Sheftell and Alice S. Batenhorst and has published in prestigious journals such as Biological Psychiatry, Journal of the American Academy of Child & Adolescent Psychiatry and Mayo Clinic Proceedings.

In The Last Decade

Stephen O’Quinn

27 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stephen O’Quinn 1.4k 1.0k 803 168 117 28 1.5k
Donna Gutterman 1.4k 1.0× 902 0.9× 700 0.9× 163 1.0× 92 0.8× 26 1.5k
BK Rasmussen 1.2k 0.8× 713 0.7× 463 0.6× 102 0.6× 89 0.8× 13 1.3k
H Massiou 1.7k 1.2× 1.1k 1.1× 730 0.9× 190 1.1× 131 1.1× 55 2.0k
Christian Lampl 1.3k 0.9× 743 0.7× 424 0.5× 144 0.9× 68 0.6× 42 1.5k
Walter F. Stewart 1.2k 0.9× 738 0.7× 431 0.5× 154 0.9× 95 0.8× 6 1.4k
Lee Kudrow 1.4k 1.0× 948 0.9× 723 0.9× 70 0.4× 57 0.5× 39 1.6k
Elena Ruiz de la Torre 1.5k 1.1× 823 0.8× 367 0.5× 141 0.8× 79 0.7× 27 1.6k
Fabio Frediani 1.1k 0.8× 644 0.6× 403 0.5× 103 0.6× 56 0.5× 78 1.3k
P Tfelt-Hansen 845 0.6× 476 0.5× 386 0.5× 109 0.6× 71 0.6× 15 1.0k
F. G. Freitag 1.0k 0.7× 574 0.6× 385 0.5× 101 0.6× 109 0.9× 9 1.1k

Countries citing papers authored by Stephen O’Quinn

Since Specialization
Citations

This map shows the geographic impact of Stephen O’Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen O’Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen O’Quinn more than expected).

Fields of papers citing papers by Stephen O’Quinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen O’Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen O’Quinn. The network helps show where Stephen O’Quinn may publish in the future.

Co-authorship network of co-authors of Stephen O’Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen O’Quinn. A scholar is included among the top collaborators of Stephen O’Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen O’Quinn. Stephen O’Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reading, Christopher L., Jiayan Yan, Marcia A. Testa, et al.. (2025). An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. Frontiers in Neuroscience. 19. 1516746–1516746. 1 indexed citations
2.
Berry‐Kravis, Elizabeth, Randi J. Hagerman, Jonathan Cohen, et al.. (2025). Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study. Journal of Neurodevelopmental Disorders. 17(1). 69–69.
3.
Palumbo, Joseph, Brian F. Thomas, Dejan B. Budimirovic, et al.. (2023). Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment. Journal of Neurodevelopmental Disorders. 15(1). 1–1. 13 indexed citations
4.
Berry‐Kravis, Elizabeth, Randi J. Hagerman, Dejan B. Budimirovic, et al.. (2022). A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). Journal of Neurodevelopmental Disorders. 14(1). 56–56. 39 indexed citations
5.
Winner, Paul, et al.. (2003). Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies. Mayo Clinic Proceedings. 78(10). 1214–1222. 74 indexed citations
6.
Moore, Katy H. P., Philip T. Leese, Scott McNeal, et al.. (2002). The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers. Clinical Therapeutics. 24(4). 583–594. 15 indexed citations
7.
Newman, Lawrence C., Stephen H. Landy, SD Silberstein, et al.. (2001). Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study. Headache The Journal of Head and Face Pain. 41(3). 248–256. 135 indexed citations
8.
Farmer, Kathleen, Roger Cady, Joseph Bleiberg, et al.. (2001). Sumatriptan Nasal Spray and Cognitive Function During Migraine: Results of an Open‐Label Study. Headache The Journal of Head and Face Pain. 41(4). 377–384. 54 indexed citations
9.
Fuseau, Eliane, Olivier Pétricoul, Adrian Pereira, et al.. (2001). Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine. Clinical Therapeutics. 23(2). 242–251. 31 indexed citations
10.
Cady, Roger, Fred D. Sheftell, Richard B. Lipton, Winghan Jacqueline Kwong, & Stephen O’Quinn. (2001). Economic implications of early treatment of migraine with sumatriptan tablets. Clinical Therapeutics. 23(2). 284–291. 23 indexed citations
11.
Lipton, Richard B., Walter F. Stewart, Roger Cady, et al.. (2001). Joint Responses From Lipton et al and Cady et al. Headache The Journal of Head and Face Pain. 41(9). 920–921. 1 indexed citations
12.
Cady, Roger, Richard B. Lipton, Charles B. Hall, et al.. (2001). Response From Cady et al. Headache The Journal of Head and Face Pain. 41(9). 921–922. 1 indexed citations
13.
Cady, Roger, Richard B. Lipton, Charles B. Hall, et al.. (2000). Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study. Headache The Journal of Head and Face Pain. 40(10). 792–797. 157 indexed citations
14.
Stark, Stuart R., et al.. (2000). Naratriptan Efficacy in Migraineurs Who Respond Poorly to Oral Sumatriptan. Headache The Journal of Head and Face Pain. 40(7). 513–520. 61 indexed citations
15.
Lipton, Richard B., Walter F. Stewart, Charles B. Hall, et al.. (2000). Sumatriptan for the Range of Headaches in Migraine Sufferers: Results of the Spectrum Study. Headache The Journal of Head and Face Pain. 40(10). 783–791. 178 indexed citations
16.
Cady, Roger, Fred D. Sheftell, Richard B. Lipton, et al.. (2000). Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials. Clinical Therapeutics. 22(9). 1035–1048. 182 indexed citations
17.
18.
Sheftell, Fred D., et al.. (2000). Low Migraine Headache Recurrence With Naratriptan: Clinical Parameters Related to Recurrence. Headache The Journal of Head and Face Pain. 40(2). 103–110. 33 indexed citations
19.
O’Quinn, Stephen, Sara A. Ephross, Vanessa C. Williams, et al.. (1999). Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Archives of Gynecology and Obstetrics. 263(1-2). 7–12. 45 indexed citations
20.
Ryan, Richella, et al.. (1998). Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack. Archives of Internal Medicine. 158(9). 1013–1013. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Gutterman Breakdown of academic impact, for papers by BK Rasmussen Breakdown of academic impact, for papers by H Massiou Breakdown of academic impact, for papers by Christian Lampl Breakdown of academic impact, for papers by Walter F. Stewart Breakdown of academic impact, for papers by Lee Kudrow Breakdown of academic impact, for papers by Elena Ruiz de la Torre Breakdown of academic impact, for papers by Fabio Frediani Breakdown of academic impact, for papers by P Tfelt-Hansen Breakdown of academic impact, for papers by F. G. Freitag
Rankless by CCL
2026